UK regulator approves J&J's oral plaque psoriasis treatment Icotrokinra Hydrochloride

The UK's Medicines and Healthcare Products Regulatory Agency has approved Johnson & Johnson's Icotrokinra Hydrochloride, an oral treatment for moderate to severe plaque psoriasis, providing a new therapeutic option for patients with the condition.

Detected & updated continuously · Source: Nebula